Dyne Therapeutics (DYN) Current Leases (2021 - 2026)
Dyne Therapeutics (DYN) recorded quarterly Current Leases of $5.0 million in Q1 2026, up 0.76% quarter-over-quarter from $5.0 million in Q4 2025, and down 1.53% on a YoY basis from $5.1 million in Q1 2025.
Dyne Therapeutics (DYN) Current Leases (2021 - 2026) Analysis & Trends
Dyne Therapeutics' Current Leases history runs 6 years deep, the most recent figure standing at $5.0 million for Q1 2026.
- In Q1 2026, Current Leases fell 1.53% year-over-year to $5.0 million; the TTM figure through Mar 2026 stood at $5.0 million (down 1.53% YoY), while the FY2025 annual figure was $5.0 million, up 2.99% from the prior year.
- Current Leases was $5.0 million for Q1 2026 at Dyne Therapeutics, up from $5.0 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $5.5 million in Q2 2022 to a low of $4.6 million in Q3 2022.
- Historically, Current Leases has averaged $4.9 million across 5 years, with a median of $4.8 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Current Leases grew 18.42% in 2022, then declined 14.14% in 2023.
- A 5-year view of Current Leases shows it stood at $4.6 million in 2022, then gained by 2.39% to $4.7 million in 2023, then climbed by 2.75% to $4.8 million in 2024, then advanced by 2.99% to $5.0 million in 2025, then gained by 0.76% to $5.0 million in 2026.
- The last three Current Leases figures came in at $5.0 million (Q1 2026), $5.0 million (Q4 2025), and $5.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Dyne Therapeutics | 3.00 Bn | 3.00 Bn | - | 5.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.03 Mn |
| Dec 31, 2025 | 5.00 Mn |
| Sep 30, 2025 | 5.04 Mn |
| Jun 30, 2025 | 5.00 Mn |
| Mar 31, 2025 | 5.11 Mn |
| Dec 31, 2024 | 4.85 Mn |
| Sep 30, 2024 | 4.81 Mn |
| Jun 30, 2024 | 4.78 Mn |
| Mar 31, 2024 | 4.76 Mn |
| Dec 31, 2023 | 4.72 Mn |
| Sep 30, 2023 | 4.71 Mn |
| Jun 30, 2023 | 4.71 Mn |
| Mar 31, 2023 | 4.64 Mn |
| Dec 31, 2022 | 4.61 Mn |
| Sep 30, 2022 | 4.58 Mn |
| Jun 30, 2022 | 5.49 Mn |
| Mar 31, 2022 | 4.71 Mn |
| Dec 31, 2021 | 3.89 Mn |
| Sep 30, 2021 | 4.59 Mn |